Venture-Backed Startups
101,671 companies with verified investor relationships.
Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.
1 investor
Uses UV light signals to boost seed and seedling genetic potential; domiciled in the USA.
8 investors
0 investors
Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
1 investor
0 investors
Biom makes plastic-free cleaning and personal-care wipes—including disinfecting, flushable, all-purpose, body, hand sanitizing, and baby wipes—using 100% plant-based fibers, along with refillable dispensers and shippable refills to reduce plastic waste. The brand sells directly to consumers for home cleaning and personal hygiene.
4 investors
Biomakers builds precision genomic data infrastructure for oncology drug and diagnostic development, focusing on Latin America's underrepresented genetic diversity. It aims to close gaps in genomic data that has historically captured only a narrow slice of human genetic diversity.
1 investor
0 investors
0 investors
Biomarq Health develops a wearable, injectable multi-analyte biosensor platform that continuously monitors biochemical markers such as glucose, lactate, ketones, cortisol, and kidney-related analytes from a single sensor. Its first product targets affordable continuous glucose monitoring for people with type 1, type 2, and pre-diabetes, with planned applications in chronic kidney disease, pregnancy monitoring, and healthspan research.
1 investor
Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.
1 investor
Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry. Founded in North Carolina with manufacturing and market development in Denmark, the company sells tile products installed in the US and Europe and is developing pavers and walls, with a focus on the European market.
2 investors
Biomass Controls builds decentralized sanitation systems, including the Biogenic Refinery, to process fecal sludge, septage, and biosolids in areas where centralized wastewater treatment is unavailable or not cost-effective. It targets low-resource and cold-climate settings such as Arctic communities in Alaska, peri-urban settlements in India, and off-grid industrial camps.
1 investor
1 investor
0 investors
Creating proteins for health and manufacturing
2 investors
Biome makes Taiga, a smart hydroponic living wall with onboard sensors, automated irrigation, and lighting that automates indoor plant care, along with the Halo grow light, plant supplements, and a companion app to monitor and control the system. It sells soil-free, fully grown living walls for home consumers, shipped from its indoor vertical greenhouse in Oakland, CA.
1 investor
0 investors
0 investors
0 investors
1 investor
BioMech develops wireless, noninvasive motion sensors and analytics software (BioMech Lab and BioMech AI) that capture and stream three-dimensional motion in real time. Its platform serves healthcare, sports/wellness, and industrial markets to quantify and improve movement outcomes.
0 investors
BioMed Central is an academic publisher of open access, peer-reviewed scientific journals, including titles such as Algorithms for Molecular Biology covering bioinformatics and molecular biology research. It serves researchers and academics across biology, medicine, and related life-science fields.
1 investor
0 investors